Design and conduct of confirmatory chronic pain clinical trials

por Katz, Nathaniel
Publicado 2020

Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions

por Katz, Nathaniel P, Paillard, Florence C, Ekman, Evan
Publicado 2015

Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT tr...

por Backonja, Miroslav, Williams, Leslie, Miao, Xiaopeng, Katz, Nathaniel, Chen, Crystal
Publicado 2017

Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic Pain

por Meske, Diana S, Vaughn, Ben J, Kopecky, Ernest A, Katz, Nathaniel
Publicado 2019

Development and preliminary validation of the focused analgesia selection test to identify accurate pain reporters

por Treister, Roi, Eaton, Thomas A, Trudeau, Jeremiah J, Elder, Harrison, Katz, Nathaniel P
Publicado 2017

Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials

por Meske, Diana S, Lawal, Oluwadolapo D, Elder, Harrison, Langberg, Valerie, Paillard, Florence, Katz, Nathaniel
Publicado 2018

Medication errors involving intravenous patient-controlled analgesia: results from the 2005–2015 MEDMARX database

por Mohanty, Maitreyee, Lawal, Oluwadolapo D., Skeer, Margie, Lanier, Ryan, Erpelding, Nathalie, Katz, Nathaniel
Publicado 2018

A Real-World Study Using Claims Data to Evaluate Possible Failure of Opioid Treatment Regimens Among Patients with Hip and/or Knee Osteoarthritis in the US

por Gandhi, Kavita, Wei, Wenhui, Huang, Ahong, Wang, Li, Iyer, Ravi, Katz, Nathaniel P
Publicado 2020

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomize...

por Gimbel, Joseph, Spierings, Egilius L.H., Katz, Nathaniel, Xiang, Qinfang, Tzanis, Evan, Finn, Andrew
Publicado 2016

NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain

por Arsenault, Pierre, Chiche, Dan, Brown, William, Miller, Jeffrey, Treister, Roi, Leff, Richard, Walker, Philippe, Katz, Nathaniel
Publicado 2018

Direct Costs of Opioid Abuse in an Insured Population in the United States

por WHITE, ALAN G., BIRNBAUM, HOWARD G., MAREVA, MILENA N., DAHER, MAHAM, VALLOW, SUSAN, SCHEIN, JEFF, KATZ, NATHANIEL
Publicado 2020

Direct Costs of Opioid Abuse in an Insured Population in the United States

por White, Alan G., Birnbaum, Howard G., Mareva, Milena N., Daher, Maham, Vallow, Susan, Schein, Jeff, Katz, Nathaniel
Publicado 2005

Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone:...

por Farrar, John T., Bilker, Warren B., Cochetti, Philip T., Argoff, Charles E., Haythornthwaite, Jennifer, Katz, Nathaniel P., Gilron, Ian
Publicado 2022

Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers

por Butler, Stephen F, Benoit, Christine, Budman, Simon H, Fernandez, Kathrine C, McCormick, Cynthia, Venuti, Synne Wing, Katz, Nathaniel
Publicado 2006

Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients

por Landsman-Blumberg, Pamela B, Katz, Nathaniel, Gajria, Kavita, D’Souza, Anna O, Chaudhari, Sham L, Yeung, Paul P, White, Richard
Publicado 2017

Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial

por Markman, John, Resnick, Malca, Greenberg, Scott, Katz, Nathaniel, Yang, Ruoyong, Scavone, Joseph, Whalen, Ed, Gregorian, Gabriela, Parsons, Bruce, Knapp, Lloyd
Publicado 2018

Accurate pain reporting training diminishes the placebo response: Results from a randomised, double-blind, crossover trial

por Treister, Roi, Lawal, Oluwadolapo D., Shecter, Jonathan D., Khurana, Nevil, Bothmer, John, Field, Mark, Harte, Steven E., Kruger, Grant H., Katz, Nathaniel P.
Publicado 2018

Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain

por Henningfield, Jack E, Gudin, Jeffrey, Rauck, Richard, Gimbel, Joseph, Tagliaferri, Mary, Doberstein, Stephen K, Di Fonzo, Carlo, Lu, Lin, Katz, Nathaniel, Siddhanti, Suresh, Schnoll, Sidney
Publicado 2020

SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain

por Markman, John, Gudin, Jeffrey, Rauck, Richard, Argoff, Charles, Rowbotham, Michael, Agaiby, Eva, Gimbel, Joseph, Katz, Nathaniel, Doberstein, Stephen K., Tagliaferri, Mary, Lu, Lin, Siddhanti, Suresh, Hale, Martin
Publicado 2019

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

por Vinik, Aaron I., Perrot, Serge, Vinik, Etta J., Pazdera, Ladislav, Jacobs, Hélène, Stoker, Malcolm, Long, Stephen K., Snijder, Robert J., van der Stoep, Marjolijne, Ortega, Enrique, Katz, Nathaniel
Publicado 2016